找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Antibodies in Cytokines; The concerted action Huub Schellekens Book 1997 Springer Science+Business Media Dordrecht 1997 Antigen.cytokine.di

[复制链接]
查看: 26245|回复: 45
发表于 2025-3-21 19:05:40 | 显示全部楼层 |阅读模式
期刊全称Antibodies in Cytokines
期刊简称The concerted action
影响因子2023Huub Schellekens
视频video
图书封面Titlebook: Antibodies in Cytokines; The concerted action Huub Schellekens Book 1997 Springer Science+Business Media Dordrecht 1997 Antigen.cytokine.di
影响因子This book, written by leading authors in the field, is thefirst to deal with all aspects of cytokine antibodies, from testmethodology and standardization to biological consequences andfunctions. It encompasses antibodies induced by cytokines usedtherapeutically and antiviral antibodies. To understand the biology,the effects of cytokine antibodies in experimental animal models andpatients are also discussed. The book is intended for researchers ofcytokine biology, pharmaceutical companies developing cytokines andcytokine antibodies as therapies, and clinicians interested inmodulating the immune system as therapy.
Pindex Book 1997
The information of publication is updating

书目名称Antibodies in Cytokines影响因子(影响力)




书目名称Antibodies in Cytokines影响因子(影响力)学科排名




书目名称Antibodies in Cytokines网络公开度




书目名称Antibodies in Cytokines网络公开度学科排名




书目名称Antibodies in Cytokines被引频次




书目名称Antibodies in Cytokines被引频次学科排名




书目名称Antibodies in Cytokines年度引用




书目名称Antibodies in Cytokines年度引用学科排名




书目名称Antibodies in Cytokines读者反馈




书目名称Antibodies in Cytokines读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:51:18 | 显示全部楼层
Interferon antibodies in patients with infectious diseases,ce the early clinical trials it was documented that the therapeutic use of IFNs could be complicated by the development of antibodies able to neutralize or to bind to the IFN molecule..After several years of research it is now widely accepted that the presence of circulating anti-IFN antibodies may
发表于 2025-3-22 01:38:00 | 显示全部楼层
Treatment-induced antibodies to interleukin-2,ired immune deficiencies, infectious disorders, and as an adjuvant to vaccines. Both natural and recombinant type IL-2 preparations have been applied in clinical treatment trials and have turned out to be immunogenic, although to a varying extent. Enzyme immunoassays and western blotting are standar
发表于 2025-3-22 07:12:47 | 显示全部楼层
发表于 2025-3-22 10:40:35 | 显示全部楼层
发表于 2025-3-22 16:40:52 | 显示全部楼层
Anti-cytokine autoantibodies: Epiphenomenon or critical modulators of cytokine action,e, are increased in the circulation of patients subjected to cytokine therapy or suffering from a variety of immunoinflammatory diseases. It has been suggested that these autoantibodies play a regulatory role in the intensity and duration of an immune response. The antibodies may prevent the binding
发表于 2025-3-22 18:02:39 | 显示全部楼层
,Potential therapeutic use of antibodies directed towards HuIFN-γ,tion and delayed-type hypersensitivity have indicated that administration of antibodies against IFN-γ can prevent the occurrence of diseases or alleviate disease manifestations. Therefore, it is speculated that such antibodies may have therapeutical efficacy in human diseases. Since animal-derived a
发表于 2025-3-23 00:22:33 | 显示全部楼层
Structure-activity of type I interferons,or and transmit signals to cellular nucleus through a similar mechanism, eliciting roughly homogeneous biological activity. Nevertheless, the members of that family, IFNα species, IFNβ and IFNω, due to local differences in the structure sometime show distinct properties. From the reported data it re
发表于 2025-3-23 03:03:39 | 显示全部楼层
发表于 2025-3-23 08:01:03 | 显示全部楼层
The Expression of Potency of Neutralizing Antibodies for Interferons and other Cytokines,mportance of establishing a common method of reporting neutralizing antibody levels for such cytokines. For quantitative neutralization bioassays, the preferred expression of the neutralizing potency of an antiserum is a titer, that is, the dilution of serum that reduces 10 Laboratory Units (LU)/ml
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-22 00:46
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表